Withdrawal of Product from Sale in the United States | Federal Regulations · Congress.wiki

Nonrulemaking

FDA

FDA-2001-P-0152

Withdrawal of Product from Sale in the United States

Documents

Comments

Description

CLOSED DATE: 05/07/2002 Docket Status: CLOSED

Type	Title	Posted	Comments	Status
Other	FDA/CDER to Aspire Pharmaceuticals Inc	May 15, 2002	--	--
Notice

CODEINE PHOSPHATE TBLTS

SAME AS TYLENOL

ASPIRE PHARMACEUTICALS

ACETAMINOPHEN

500MG/60MG WITHDRAWN

500/15 MG

500MG/30MG

CDER